This guidance is intended to assist sponsors of investigational new drug applications and applicants of new drug applications, biologics license applications and supplements to such applications who are planning to conduct clinical studies in neonatal populations.
This guidance provides recommendations for neonatal clinical pharmacology studies and will be useful for education and practice.
Additional tools (graphical snapshot, podcasts) can be found here:
The next conference is already in preparation!
Pavla Pokorna, our president elect and educational officer on research will host this meeting in Prague, CZ. We are already working on the program proposal and will do our best to celebrate the 35th ESDPPPP anniversary.
Stay tuned and visit our conference homepage for the latest details and information:
Our societies 19th Conference, hosted by our president Mark Turner in Liverpool, was a success and wonderful experience - especially to meet in-person again and to have the possibility to gain knowledge on-site after two predominant pandemic years.
Slides, posters and all abstracts will be provided in our "Members Only" area - have a look!
IUPHAR is responding to the current crisis by coordinating pharmacological resources worldwide. Although most of the current research is done in adults, we believe
in part it may be relevant for pediatric pharmacologists as well.
Based in Ghent, Belgium, ESDPPP promotes research in developmental perinatal and paediatric pharmacology and offers a forum for dialogue between pharmacologists, clinicians, and scientists interested in the effect of medicines on the developing fetus, infant, and child.
The ESDPPP celebrated its 35th anniversary in 2023. This milestone provides an important opportunity to celebrate ESDPPP’s achievements to date and to describe our future aspirations and ambitions on behalf of millions of paediatric patients worldwide.
We aim to improve medicines for children and advance research and global access to paediatric medicines. We also advocate politically for the continued development of safe, evidence-based medications for children. In this respect, ESDPPP works closely with European Medicines Agency (EMA), International Union of Basic and Clinical Pharmacology (IUPHAR) and the World Health Organization (WHO).
Meeting our collegues is very important for our society. We enjoyed a wonderful congress in Liverpool, UK, in June 2022 and are looking forward to our next congress, which will be held in Prague (2023). We are welcoming your ideas and suggestions for these events.
Join us on LinkedIn!!
We want to use LinkedIn for announcements and discussions in our field. Please check out our group page on LinkedIn and become a group member.
The official journal of the ESDPPP is the leading paediatric journal Archives of Disease in Childhood. It contains a Drug Therapy section which is published every 3 months.
ESDPPP is associated with a range of organizations like EMEA, IUHAR and WHO. Additional information on projects, initiatives and conferences will be available within short.
In 2023 ESDPPP celebrated its 35th anniversary at the society's 20th conference in Prague, CZ. The meeting will be hosted by our new president Pavla Pokorna.
After the congress
Our last congress in Liverpool was a great success and a meeting place for many. Did you enjoy it as well? Become a member of ESDPPP and be the first to know more about the next congress in Prague…
ESDPPP VZW p/a University Hospital
Gasthuisberg Herestraat 49
The primary aim of the society is to promote research in the field of paediatric pharmacology and to offer a forum for exchange between pharmacologists and clinical physicians about more adequate drug administration.
Join us on LinkedIn